Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists

Dynavax Technologies announced that the U.S. Patent Office has issued the company a broad composition of matter patent covering the company’s proprietary second-generation TLR9 agonists.
Yahoo Finance